Sunday, January 8, 2017

UPDATE 2-France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal

Jan 9 (Reuters) - French drugmaker Ipsen SA said on

Monday it would buy some assets of Merrimack Pharmaceuticals Inc

, including pancreatic cancer drug Onivyde, for up to $1

billion, barely a month...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)